Mission & Vision

Mission

Contributing to social welfare by taking a part in the pharmaceutical supply chain that delivers therapeutic drugs to people suffering from illness and creating innovative drug seeds that can defeat  intractable diseases with improving  the quality of life (QOL). Through research activities for innovative drug discovery, we will contribute to the future development of science and technology.

Corporate Philosophies

Contributing to society through creating innovative new drug seeds
that can treat intractable diseases.

Our vision in the drug discovery business is to create new drug seeds that can defeat intractable diseases and improve patient’s quality of life (QOL)through innovative research and development activities.

Pursue sound profits and manage the company with financial independence.

We aim to reward all stakeholders, including shareholders, by managing the company by covering R&D and capital investment within the range of our own profits.

Provide a work environment where all employees are respected
as individuals and can feel secure.

We will respect the diversity of all officers and employees, provide a sense of accomplishment through work, and provide a safe working environment in which they are treated appropriately.

Keep the right ethical values and venture spirit.

We do our business based on right ethical values and social justice, and as a venture company, we never forget to take on challenges without fear of failure.

Management Vision

1. Our company will focus on research and development of immunomodulation drugs, with special interest in dendritic cell, targeting autoimmune diseases and cancer, and will boldly take on the challenge of new drug discovery areas.

2. Our company devote to create new drug seeds for First-in-class (breakthrough new drug) or Best-in-class (improved new drug), which are expected to obtain strong patent rights based on our own discoveries.

3. Our company’s basic business strategy is to licenses our drug seeds at the early stage of development and entrusts the clinical stage and beyond to pharmaceutical companies in order to deliver new drugs to patients more quickly and surely.

4. By accumulating the number of licensed out drug seeds, we will stabilize our company’s profits level , secure future R&D funds. At same time shareholders, officers and employees should realize a fair return.

5. Our company recognize that the drug discovery business involves extremely high risks. We will manage our business with optimization of the balance between risk mitigation and risk taking for future business expansion.